Diethylstilbestrol (DES) labeled with Auger emitters: Potential radiopharmaceutical for therapy of estrogen receptor-positive tumors and their metastases?

International Journal of Radiation Biology

Volumn 84, Issue 12, 2008, Pages 1112-1122

  Fischer, Thomas ^a   Schomäcker, Klaus ^a   Schicha, Harald ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Auger electron emitter; Breast cancer; Estrogens; Radionuclide therapy

Indexed keywords

ASCORBIC ACID; DIETHYLSTILBESTROL; DIETHYLSTILBESTROL I 123; DIETHYLSTILBESTROL I 125; DIETHYLSTILBESTROL I 131; ESTROGEN RECEPTOR; FREE RADICAL; IODINE 131; RADIOPHARMACEUTICAL AGENT; SODIUM IODIDE I 123; SODIUM IODIDE I 125; SODIUM IODIDE I 131; TETRAZOLIUM; UNCLASSIFIED DRUG;

BINDING AFFINITY; BREAST ADENOCARCINOMA; CELL VIABILITY; CONFERENCE PAPER; CONTROLLED STUDY; DNA FRAGMENTATION; DRUG CYTOTOXICITY; DRUG MECHANISM; DRUG RECEPTOR BINDING; HUMAN; HUMAN CELL; ISOTOPE LABELING; METASTASIS; PRIORITY JOURNAL; RADIATION PROTECTION; RADIOACTIVITY;

ADENOCARCINOMA; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL SURVIVAL; DIETHYLSTILBESTROL; HUMANS; IODINE RADIOISOTOPES; NEOPLASM METASTASIS; NEOPLASMS, HORMONE-DEPENDENT; RADIOPHARMACEUTICALS; RECEPTORS, ESTROGEN;

EID: 57349150349     PISSN: 09553002     EISSN: 13623095     Source Type: Journal    
DOI: 10.1080/09553000802499238     Document Type: Conference Paper

References (40)

1. Adelstein SJ. 1993. The Auger process: A therapeutic promise? American Journal of Roentgenology 160:707.
2. 125I decay. Mutation Research 10:247-250.
3. Albanese J, Dainiak N. 2003. Modulation of intercellular communication mediated at the cell surface and on extracellular, plasma membrane-derived vesicles by ionizing radiation. Experimental Hematology 31:455-464.
4. Aronson NN, Touster O. 1974. Isolation of rat liver plasma membrane fragments in isotonic sucrose. In: Fleischer S, Packer L, editors. Methods in enzymology XXXI, Part A, Biomembranes. New York: Academic Press.
5. Beckmann MW, Scharl A, Göhring U, Niederacher D, Holt JA. 1994. Durch Konversionselektronen verursachte und östrogenrezeptorvermittelte Zytotoxizität von 16alpha-Radioiod-17beta-Östradiol in Mammakarzinomzellen in vitro. Tumordiagnostik und Therapie 15:17-20.
6. Bloomer WD, Adelstein SJ. 1977. 5-(I-125)-iododeoxyuridine as prototype for radionuclide therapy with Auger emitters. Nature (London) 265:620-621.
7. Bloomer WD, Adelstein SJ. 1978. 5-(I-125)-iododeoxyuridine and the Auger effect: Biological consequences and implications for therapy. Pathobiology Annual 8:407-421.
8. Bloomer WD, Adelstein SJ. 1981. Iodine-125 cytotoxicity: implications for therapy and estimation of radiation risk. International Journal of Nuclear Medicine and Biology 8:171-178.
9. Bloomer WD, McLaughlin WH, Adelstein SJ. 1982. Therapeutic implications of iodine-125 cytotoxicity. International Journal of Radiation Oncology Biology Physics 8:1903-1908.
10. Bloomer WD, Mc Laughlin WH, Milius RA, Weichselbaum RR, Hanson RN, Adelstein SJ, Seitz DE. 1983. Estrogen receptor-mediated cytotoxicity using I-125. Journal of Cell Biochemistry 21:39-45.
11. Bloomer WD, McLaughlin WH, Weichselbaum RR, Hanson RN, Adelstein SJ, Seitz DE. 1981. The role of subcellular localization in assessing the cytotoxicity of labeled iododeoxyuridine, iodotamoxifen, and iodoantipyrine. Journal of Radioanalytical Chemistry 65:209-213.
12. Bloomer WD, Mc Laughlin WH, Weichselbaum RR, Tonneson GL, Hellman S, Seitz DE, Hanson RN, Adelstein SJ, Rosner AL, Burstein NA, Nove JJ, Little JB. 1980. Iodine-125-labelled tamoxifen is differentially cytotoxic to cells containing estrogen receptors. International Journal of Radiation Biology 38:197-202.
13. Bradley EW, Chan PC, Adelstein SJ. 1975. The radiotoxicity of iodine-125 in mammalian cells. I. Effects on the survival curve of radioiodine incorporated into DNA. Radiation Research 4:555-563.
14. Buchegger F, Perillo-Adamer F, Dupertuis YM, Bischof-Delaloye A. 2006. Auger radiation targeted into DNA: A therapy perspective. European Journal of Nuclear Medicine and Molecular Imaging 33:1352-1363.
15. 125I in cell DNA at -196°C. International Journal of Radiation Biology 24:363.
16. Chan PC, Lisco E, Lisco H, Adelstein SJ. 1976. The radiotoxicity of iodine-125 in mammalian cells. II. A comparative study on cell survival and cytogenetic response to I-125-UdR, I-131-UdR and H-3-TdR. Radiation Research 67:332-343.
17. DeSombre ER, Hughes A, Hanson RN, Kearney T. 2000. Therapy of estrogen receptor-positive micrometastases in the peritoneal cavity with Auger-electron-emitting estrogens - theoretical and practical considerations. Acta Oncologica 39:659-666.
18. Dodds EC, Goldberg L, Lawson W, Robinson R. 1938. Estrogenic activity of certain synthetic compounds. Nature (London) 141:247-248.
19. Feinendegen LE. 1975. Biological damage from the Auger effect, possible benefits. Radiation and Environmental Biophysics 12:85.
20. Feinendegen LE, Henneberg P, Tisljar-Lentulis G. 1977. DNA strand breakage and repair in human kidney cells after exposure to incorporated iodine-125 and cobalt-60 γ-rays. Current Topics in Radiation Research 12:436.
21. natI-DES. Journal of Labelled Compounds and Radiopharmaceuticals 47:669-678.
22. Goddu SM, Howell RW, Rao DV. 1994. Cellular dosimetry: Absorbed fractions for monoenergetic electron and alpha particle sources and S-values for radionuclides uniformly distributed in different cell compartments. Journal of Nuclear Medicine 35:303-316.
23. Humm JL, Howell RE, Rao DV. 1994. Dosimetry of Auger-electron-emitting radionuclides: report No.3 of AAPM Nuclear Medicine Task Group No.6. Medical Physics 21:1901-1915.
24. Kassis AI, Adelstein SJ. 2005. Radiobiologic principles in radionuclide therapy. Journal of Nuclear Medicine 46:4S-12.
25. Kassis AI, Sastry KSR, Adelstein SJ. 1987. Kinetics of uptake, retention, and radiocytotoxicity of I-125 IUdR in mammalian cells: Implication of localized energy deposition by Auger processes. Radiation Research 109:78-89.
26. Korach KS, Chae K, Gibson M, Curtis S. 1991. Estrogen receptor stereochemistry: Ligand binding and hormonal responsiveness, Steroids 56:263-270.
27. Krisch RE. 1972. Lethal effects of I-125 decay by electron capture in Escherichia coli and bacteriophage T1. International Journal of Radiation Biology 21:167-189.
28. Krisch RE, Sauri CJ. 1975. Further studies of DNA damage and lethality from the decay of iodine-125 in bacteriophages. International Journal of Radiation Biology 27:553-560.
29. Lieberman ME, Gorski J, Jordan VC. 1983. An estrogen receptor model to describe the regulation of prolactin synthesis by antiestrogens in vitro. Journal of Biological Chemistry 258:4741-4745.
30. 123I-Diethystilbestrolphophate - a potential tracer for receptorimaging and therapy? European Journal of Nuclear Medicine 21:878 (abstract).
31. Mende T, Hennig K, Wollny G, Gens J. 1978. Experimentelle Untersuchungen über die Verteilung von intravenös injiziertem jodmarkiertem Cytonal (Diäthylstilböstroldiphosphat). Zeitschrift für Urologie und Nephrologie 71:529-534.
32. Mende T, Hennig K, Wollny G, Gens J, Zotter S. 1979. Verteilung von Jod-markiertem Diäthylstilböstroldiphosphat nach intravenöser Injektion. Gynäkologische Rundschau 19:30-36.
33. O'Donoghue JA, Wheldon TE. 1996. Targeted radiotherapy using Auger electron emitters. Physics in Medicine and Biology 41:1973-1992.
34. Sastry KSR. 1992. Biological effects of the Auger emitter iodine-125: A review. Report No 1 of AAPM Nuclear Task Group No 6. Medical Physics 19:1361-1370.
35. 125I]-Iodöstradiol-3,17β. Nuklearmedizin 37:134-140.
36. Schomäcker K, Fischer T, Löhr H, Moka D, Scheidhauer K, Schicha H. 1999. Biokinetics of I-123-Diethylstilbestrol (DES) in mamma-carcinoma bearing mice. Journal of Nuclear Medicine 40:100P (abstract).
37. Schomäcker K, Meller-Rehbein B, Gabruk-Szostak B, Gerard H, Scheidhauer K, Scharl A. 1997. Investigations into biokinetics of I-123 Diethylstilbestrol phosphate in tumour-bearing mice. In: Bergmann H, Kroiss A, Sinzinger H, editors. Radioactive isotopes in clinical medicine and research, Basel: Birkhäuser Verlag. pp 333-342.
38. 131I labeled diethylstilbestrol diphosphate and its potential use in nuclear medicine. Journal of Nuclear Medicine 5:1-15.
39. 131I labeled diethylstilbestrol diphosphate in animals and men with observations on its potential use as a scanning agent of the prostate. Journal of Nuclear Medicine 5:184-202.
40. 125I-oestrogen decay in non-oestrogen receptor-expressing human breast cancer cells, MDA-231 and oestrogen receptor-expressing MCF-7 cells. International Journal of Radiation Biology 77:955-962.